Unlearn Ai

Unlearn Ai

  • Founded in 2020
  • 51-200 Employees
  • Venture Round on 2023-03

Careers at Unlearn Ai


About Unlearn Ai

Unlearn. AI is a clinical research company that leverages artificial intelligence technology to enhance the process of clinical trials. The company specializes in creating digital twins of patients using its state-of-the-art platform, which aims to improve the accuracy and efficiency of clinical trials. By predicting clinical outcomes with precision at every future time point, Unlearn. AI supports data-driven decision-making and optimizes trial timelines. The platform enables smaller, cost-effective trials without compromising their power, and identifies sensitive clinical outcomes through detailed disease modeling, notably accelerating clinical development in various diseases, including Alzheimer's. The solutions offered by Unlearn. AI align with current FDA and EMA guidelines.